As FDA Commissioner Robert Califf prepares to step down from his post to make way for a Trump administration replacement, former Acting Commissioner Stephen Ostroff may step into the breach.
Robert Califf has formally scheduled the end of his time as FDA commissioner and it appears a familiar face might temporarily take his place.
Stephen Ostroff, deputy commissioner for foods and veterinary medicine, appears in line to become the temporary acting commissioner, assuming Califf departs as scheduled and the incoming Trump administration does not designate someone else to run the agency in the short term
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
